Australia's largest stock trading and investment forum Australia's #1 stock forum

KDR

Click for more information

0.00%

$1.90 kidman resources limited

Thanks Haplo. A great read. Anyone invested in KDR should take...

First 75 Last

Share
Profile

Follow
suds100

737 Posts.

168

24/10/18

13:52

Post #: 36241625
Share

Originally posted by Haplo ↑

Tesla critic and short seller Citron makes U-turn ahead of results and has gone long. At time of posting, Tesla is up more than 10% on the new. Tesla is also expected to post its earnings report tomorrow, that will show that it is nearly profitable or may even surprise with profitability.

View attachment 1342517

Here is a link to the Citron research note on Tesla. Worth reading.

Citron research note

Tesla becoming profitable is a pivotal moment in the EV transition movement. Tesla was expected to fail but far from it - it is now so advanced compared to its competitors, that some legacy car manufacturers are now truly facing their Kodak moment.

As long-termers know, KDR has an offtake agreement with Tesla. At the time of that announcement, many down-rampers said it was a mute point because Tesla would never be profitable. Once again they were wrong, just as they were wrong when they said MZN would win ownership of Mt Holland.

KDR's future is looking brighter than ever. How long before shorters remove their positions on major lithium stocks? With Tesla now being profitable, not long I think.

Haplo

Expand

Thanks Haplo. A great read. Anyone invested in KDR should take the time to read this report.

KDR Price at posting: $1.09 Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 4 more messages in this thread...

First 75 Last

Add KDR (ASX) to my watchlist